Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01631617 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Treatments on Atopic Dermatitis

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 300 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fields
  2. Interventions: Cephalexin (Drug), Doxycycline (Drug), Placebo Sodium hypochlorite (Other), Placebo capsules (Other), Sodium hypochlorite (Other)… to Cephalexin (Drug), Doxycycline (Drug), Placebo Sodium hypochlorite (Other), Placebo capsules (Other), Sodium hypochlorite (Other)…
    • Eligibility criteria expanded, about 66 words
    • Study description expanded, about 18 words
  3. 27 versions Re-verified since Dec 31, 2025, no change to tracked fieldsv272-v298
  4. Study Status, Contacts/Locationsv271
  5. 17 versions Re-verified since Aug 9, 2025, no change to tracked fieldsv254-v270
Show 3 earlier versionsHide 3 earlier versions
  1. Eligibility criteria revised
    • Study description revised
    v253
  2. Study Status, Study Description, Eligibilityv252
  3. Re-verified, no change to tracked fieldsv251
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: \- Atopic dermatitis, or eczema, is a chronic skin disorder. Patients sometimes have infections with S. aureus bacteria. Researchers want to study how eczema treatments affect the number and the type of bacteria on the skin. Objectives: \- To study the effect of eczema treatments on skin bacteria. Eligibility: * Individuals between 2 and 25 years of age who have moderate to severe atopic dermatitis. * Healthy volunteers between 18 and 40 years of age with no history of eczema. Design: * Participants will be screened with a physical exam and medical history. Research samples will be collected. Skin biopsies may also be performed. * All participants will be assigned to one of several study groups. * Healthy volunteers must not have taken antibiotics in the year before the start of the study. * All participants will have regular study visits during their 1-year participation. More research samples will be collected at these visits. * Healthy volunteers may be asked to come in for a one-time follow up after the 1 year mark.
Trial Details
NCT Number NCT01631617
Lead Sponsor National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Conditions
(from sponsor)		 Eczema, Dermatitis, Skin Diseases, Genetic, Dermatitis, Atopic, Skin Diseases
Related terms Dermatitis, Dermatitis, Atopic, Eczema, Skin Diseases, Skin Diseases, Genetic
Enrollment 130 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov